Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
10.1016/j.jhep.2008.02.022
Saved in:
Main Authors: | Huynh, H., Yu, K., Wu, J., Lee, M.H., Hor, H., Soo, K.C., Toh, H.C., Tan, P., Salto-Tellez, M., Chow, P.K.H., Lee, C.K., Soong, R., Goh, B.C., Lee, H.S., Somani, A., Tan, P.H., Palanisamy, N., Kalpana, R. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/27371 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
by: Huynh, H., et al.
Published: (2012) -
ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft
by: Jasinghe, V.J., et al.
Published: (2011) -
γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model
by: Siveen, K.S., et al.
Published: (2014) -
EFFECTS OF INHIBITING THE MAMMALIAN TARGET OF RAPAMYCIN (MTOR) PATHWAY AND TELOMERASE IN BREAST CANCER CELLS
by: GOPALAKRISHNAN KALPANA
Published: (2011) -
KINASE-INDEPENDENT AND DEPENDENT MECHANISMS OF MAMMALIAN TARGET OF RAPAMYCIN IN MODULATING CELLULAR HOMEOSTASIS
by: TAN WEI QUAN BRYCE
Published: (2023)